Scopolamine Transdermal Patch and Diphenoxylate: Interaction Details
- Scopolamine Transdermal Patch
- Transderm Scop
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Scopolamine Transdermal Patch and Diphenoxylate interaction:
Diphenoxylate
We don't have a drug information page for Diphenoxylate yet. Have a question about Diphenoxylate? Ask a pharmacist, free →
Scopolamine Transdermal Patch
- Transderm Scop
What Happens When You Take Scopolamine Transdermal Patch With Diphenoxylate
What can happen when they are taken together (rated Major)
Increased or potentiated scopolamine effects and an increased risk of
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
When scopolamine is taken together with other agents that produce adverse effects such as drowsiness, dizziness, or disorientation (for example, sedatives, hypnotics, opiates, and anxiolytics), the effects of scopolamine may be enhanced. Depending on how important each drug is for the patient, either scopolamine or the CNS depressant should be selected rather than using both. Where cannot be avoided, patients should be monitored for CNS adverse reactions.1
The Scopolamine Transdermal Patch and Diphenoxylate Interaction, Explained
Diphenoxylate (usually sold combined with atropine to treat diarrhea) is an -type medicine, and the scopolamine patch (used for motion sickness or nausea) can cause drowsiness, dizziness, and confusion on its own. Using both may make these effects stronger, so you could feel sleepier, lightheaded, or foggy than expected. This concern is based mainly on how the drugs are expected to act, not on large studies.
Don't stop or change anything on your own. Tell your pharmacist or doctor you are using both. They can decide which one is more important for you and watch how you respond, so this can be managed safely.
Mechanism: (PD). Scopolamine (antimuscarinic) can cause drowsiness, dizziness, and disorientation. Diphenoxylate is an (meperidine congener) with -depressant potential, particularly in overdose or at higher doses. It is typically formulated with atropine, adding burden.
- Direction: of scopolamine CNS effects; increased CNS depression risk.
- Severity/evidence: rated major; evidence theoretical; onset unspecified.
- Management: choose scopolamine or the CNS depressant based on the importance of each to the patient. If is unavoidable, monitor for CNS adverse reactions (, dizziness, disorientation). Consider added anticholinergic effects.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Scopolamine Transdermal Patch and Diphenoxylate Interact
The likely mechanism
How to Manage the Scopolamine Transdermal Patch and Diphenoxylate Interaction
Your care team may weigh which of the two medicines matters most for you, since one may be chosen over the other. If you need both, they may monitor you more closely for drowsiness, dizziness, or confusion.
- Keep taking both as prescribed unless your pharmacist or prescriber tells you otherwise.
- Let them know about any sleepiness, dizziness, or disorientation.
- Be careful with driving or other tasks needing alertness until you know how you respond.
- Review any other sedating medicines you take with your care team.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Scopolamine Transdermal Patch or Diphenoxylate need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Scopolamine Transdermal Patch and Diphenoxylate: Common Questions
How serious is the Scopolamine Transdermal Patch and Diphenoxylate interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Scopolamine Transdermal Patch and Diphenoxylate interaction managed?
Your care team may weigh which of the two medicines matters most for you, since one may be chosen over the other. If you need both, they may monitor you more closely for drowsiness, dizziness, or confusion. Keep taking both as prescribed unless your pharmacist or prescriber tells you otherwise. Let them know about any sleepiness, dizziness, or disorientation. Be careful with driving or other tasks… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Scopolamine Transdermal Patch and Diphenoxylate Interaction
Ask in your own words about taking Scopolamine Transdermal Patch and Diphenoxylate together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: TRANSDERM SCOP transdermal system patch, scopolamine transdermal system patch. Baxter Healthcare Corporation (per FDA), Deerfield, IL, 2025. DailyMed
Other Serious Interactions of Scopolamine Transdermal Patch and Diphenoxylate
Also serious with Diphenoxylate
- IsocarboxazidContraindicated
- NaltrexoneContraindicated
- Naltrexone and BupropionContraindicated
- Olanzapine / Samidorphan L-MalateContraindicated
Also serious with Scopolamine Transdermal Patch
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.